What is the recommended follow-up for women with a history of lobular carcinoma in situ (LCIS)?

For women with a history of lobular carcinoma in situ (LCIS), the recommended follow-up involves annual clinical breast examinations, which may also include mammography. LCIS is considered a marker for an increased risk of developing breast cancer in either breast, rather than being classified as cancer itself. As a result, careful monitoring is essential to ensure early detection of any subsequent abnormalities or the development of breast cancer.

Annual clinical breast exams allow healthcare providers to perform thorough evaluations of breast tissue changes, while mammography can help identify any potential malignancies that may arise. This proactive approach is crucial as it balances the need for surveillance without subjecting patients to unnecessary worry, given that LCIS itself does not require intervention but indicates heightened vigilance in monitoring breast health.

In contrast, infrequent imaging or solely relying on monthly self-exams would not provide adequate oversight for such individuals, as neither option ensures comprehensive evaluation by a healthcare professional. Meanwhile, the notion that no follow-up is needed is not advisable, given the established increased risk associated with a diagnosis of LCIS.